Height and risk of sudden cardiac death: the Atherosclerosis Risk in Communities and Cardiovascular Health studies

Michael A Rosenberg1, Faye L Lopez2, Petra Bůžková3

  • 1Division of Cardiac Electrophysiology, Veteran's Administration Hospitals of Boston, Harvard Medical School, West Roxbury, MA; Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston.

Annals of Epidemiology
|December 24, 2013
PubMed

Insights

Taller height is linked to a reduced risk of sudden cardiac death (SCD) in adults. This finding emerged from analyses of two large population studies, suggesting height is a factor in cardiovascular health.

Area of Science:

  • Cardiology
  • Epidemiology
  • Public Health

Background:

  • Sudden cardiac death (SCD) is a significant cause of mortality in adults.
  • Height shows a complex relationship with cardiovascular health, including associations with cardiac hypertrophy, arrhythmias, and coronary heart disease.

Purpose of the Study:

  • To investigate the association between adult height and the risk of SCD.
  • To analyze this relationship in two large, diverse population-based cohorts.

Main Methods:

  • Utilized data from the Cardiovascular Health Study and the Atherosclerosis Risk in Communities study.
  • Examined physician-adjudicated SCD events over extended follow-up periods (11.7 and 12.6 years).
  • Conducted a fixed-effects meta-analysis to pool results and assess the overall association.

Main Results:

  • A trend toward decreased SCD risk was observed with increasing height in both cohorts.
  • Meta-analysis revealed a statistically significant pooled hazard ratio of 0.84 per 10 cm of height (95% CI, 0.73-0.98; P = .03).
  • The association was slightly attenuated by factors like hypertension and left ventricular hypertrophy and appeared stronger in men.

Conclusions:

  • Greater adult height is associated with a lower risk of sudden cardiac death.
  • This finding was consistent across two distinct population-based prospective cohorts.
  • Height may be a modifiable or observable factor influencing SCD risk.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
973